Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U1 small nuclear 153, pseudogene (RNU1-153P) is a genomic sequence that closely resembles the functional U1 small nuclear RNA gene but is classified as a pseudogene[1][4]. Pseudogenes are generally non-functional copies of genes, usually lacking the capacity to encode a functional product or to participate in biological processes[1][4]. This particular pseudogene is annotated in genomics databases but does not encode a protein or RNA that performs a defined function[1][4]. The canonical functional counterparts, such as U1 small nuclear RNA, play key roles in pre-mRNA splicing as part of the U1 small nuclear ribonucleoprotein (snRNP) complex[2][3]. These snRNAs bind at the 5' exon-intron junction of pre-mRNA, initiating spliceosome assembly and enabling splice site recognition[2][3]. However, RNU1-153P itself is not involved in splicing and carries no known biological activity or therapeutic target status[1][4]. - A pseudogene designation (such as RNU1-153P) typically means the locus is not transcribed into a functional RNA and/or lacks biological function. - There are no known disease associations, drug interactions, mechanism of action, biomarker roles, or safety concerns specifically reported for RNU1-153P[1][4]. Summary: RNU1-153P is not a receptor, enzyme, transporter, or any canonical therapeutic target but rather a genomic pseudogene related to the U1 snRNA gene family, with no reported functional, pharmacological, or biomarker relevance[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U1 small nuclear 153, pseudogene (RNU1-153P).